What is Immco Diagnostics?
Founded in 1971 and headquartered in Buffalo, New York, Immco Diagnostics, Inc. (IMMCO) stands as a global leader in autoimmune diagnostics services and the manufacturing and distribution of medical devices. The company has a deep-rooted commitment to research and development, leveraging cutting-edge methodologies to diagnose a broad spectrum of diseases. IMMCO is poised to introduce proprietary technologies in the near future, aiming to expand the frontiers of autoimmunity and further solidify its competitive edge in the global market.
How much funding has Immco Diagnostics raised?
Immco Diagnostics has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for Immco Diagnostics?
The recent major strategic investment signals a pivotal growth phase for Immco Diagnostics. This capital infusion is expected to fuel further innovation in their proprietary diagnostic technologies and potentially expand their market reach in autoimmune disease detection and medical device manufacturing. The company's long history and focus on R&D suggest a strategic deployment of these funds towards enhancing their global leadership in specialized diagnostics.
See full Immco Diagnostics company page
